Related Experiment Video
Updated: May 25, 2026
03:07
Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas
Published on: November 11, 2025
[Obesity and pancreatic diseases]
1Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea. hgkim@cu.ac.kr
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi
|February 1, 2012
Summary
Obesity and overweight increase the risk of pancreatitis and pancreatic cancer. These conditions worsen acute pancreatitis outcomes and are linked to higher mortality rates for pancreatic cancer.
Area of Science:
- Gastroenterology and Oncology
- Metabolic Syndrome Research
Context:
- Obesity, defined as a body mass index (BMI) over 30, is a growing global health concern.
- Overweight (BMI 25-29.9) and obesity are increasingly recognized as significant risk factors for various pancreatic diseases.
- Existing research indicates a strong correlation between excess body weight and pancreatic pathologies.
Purpose:
- To elucidate the multifaceted role of obesity and overweight in the development and progression of pancreatic diseases.
- To examine the impact of obesity on acute, chronic, and cancerous pancreatic conditions.
- To explore the underlying pathophysiological mechanisms linking obesity to pancreatic disease.
Summary:
- Obesity is a significant risk factor for pancreatitis and pancreatic cancer, leading to more frequent and severe acute pancreatitis with increased complications.
- Overweight and obesity are associated with a higher risk of pancreatic cancer, often with an earlier age of onset, and are linked to poor prognosis and increased mortality.
- Mechanisms include increased inflammation, fat necrosis, insulin resistance, and hyperinsulinemia, which promotes pancreatic cancer cell proliferation. Physical activity may mitigate risk.
Impact:
- Highlights obesity as a critical modifiable risk factor for pancreatic diseases, emphasizing the need for weight management strategies.
- Provides insights into the pathophysiological links between metabolic dysfunction and pancreatic cancer, potentially informing targeted therapies.
- Underscores the importance of physical activity in reducing pancreatic cancer risk, particularly for overweight individuals.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.